Cite

HARVARD Citation

    Otake, K. et al. (2016). Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438). Advances in therapy. 33 (7), pp. 1140-1157. [Online]. 
  
Back to record